{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:54:37Z","timestamp":1793019277492,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1124\/jpet.122.001192","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T10:15:13Z","timestamp":1664014513000},"page":"182-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Interactive Effects of \u00b5-Opioid and Adrenergic-\u03b12 Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine"],"prefix":"10.1016","volume":"383","author":[{"given":"Samuel","family":"Obeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-2381","authenticated-orcid":false,"given":"Francisco","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio D.","family":"Zuarth Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Chaves Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea R.","family":"Gamez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Guerrero Calvache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.C.","family":"Pallares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Helmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura K.","family":"Shiomitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan J.","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-061X","authenticated-orcid":false,"given":"Jenny L.","family":"Wilkerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takato","family":"Hiranita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001192_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.biopsych.2004.08.019","article-title":"Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions","volume":"57","author":"Arnsten","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.122.001192_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jat\/bkz108","article-title":"CYP450-mediated metabolism of mitragynine and investigation of metabolites in human urine","volume":"44","author":"Basiliere","year":"2020","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.122.001192_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/dmd.121.000640","article-title":"The lack of contribution of 7-hydroxymitragynine to the antinociceptive effects of mitragynine in mice: a pharmacokinetic and pharmacodynamic study","volume":"50","author":"Berthold","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.122.001192_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1139\/Y10-007","article-title":"Involvement of imidazoline and opioid receptors in the enhancement of clonidine-induced analgesia by sulfisoxazole","volume":"88","author":"Boxwalla","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/jpet.122.001192_bib5","first-page":"343","article-title":"\u03b12-adrenergic receptor subtypes - novel functions uncovered in gene-targeted mouse models","volume":"96","author":"Brede","year":"2004","journal-title":"Biol Cell"},{"key":"10.1124\/jpet.122.001192_bib6","doi-asserted-by":"crossref","first-page":"16553","DOI":"10.1021\/acs.jmedchem.1c01111","article-title":"Oxidative metabolism as a modulator of kratom\u2019s biological actions","volume":"64","author":"Chakraborty","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001192_bib7","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.122.001192_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3810\/pgm.2014.09.2801","article-title":"The potential for misuse and abuse of medications in ADHD: a review","volume":"126","author":"Clemow","year":"2014","journal-title":"Postgrad Med"},{"key":"10.1124\/jpet.122.001192_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156802607779318190","article-title":"Interest of \u03b12-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives","volume":"7","author":"Crassous","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/jpet.122.001192_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0304-3959(88)90042-5","article-title":"Synergy between the antinociceptive effects of intrathecal clonidine and systemic morphine in the rat","volume":"32","author":"Drasner","year":"1988","journal-title":"Pain"},{"key":"10.1124\/jpet.122.001192_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229646","article-title":"Evaluating kratom alkaloids using PHASE","volume":"15","author":"Ellis","year":"2020","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001192_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107946","article-title":"Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through \u03b1-adrenoceptor mechanism","volume":"209","author":"Foss","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.122.001192_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/med.20134","article-title":"\u03b12-agonists as analgesic agents","volume":"29","author":"Giovannoni","year":"2009","journal-title":"Med Res Rev"},{"key":"10.1124\/jpet.122.001192_bib14","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","volume":"5","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/jpet.122.001192_bib15","doi-asserted-by":"crossref","first-page":"PL195","DOI":"10.1016\/S0024-3205(00)00457-4","article-title":"Intrathecal endomorphin-1 produces antinociceptive activities modulated by alpha 2-adrenoceptors in the rat tail flick, tail pressure and formalin tests","volume":"66","author":"Hao","year":"2000","journal-title":"Life Sci"},{"key":"10.1124\/jpet.122.001192_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108671","article-title":"Race, pain, and opioids among patients with chronic pain in a safety-net health system","volume":"222","author":"Haq","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.122.001192_bib17","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00213-015-3866-5","article-title":"Discriminative stimulus properties of mitragynine (kratom) in rats","volume":"232","author":"Harun","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001192_bib18","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1111\/bph.15832","article-title":"The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine","volume":"179","author":"Hill","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001192_bib19","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00213-019-05247-7","article-title":"The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats","volume":"236","author":"Hiranita","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001192_bib20","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/acsptsci.0c00075","article-title":"Metabolism of a kratom alkaloid metabolite in human plasma increases its opioid potency and efficacy","volume":"3","author":"Kamble","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/jpet.122.001192_bib21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acscentsci.9b00141","article-title":"7-Hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects","volume":"5","author":"Kruegel","year":"2019","journal-title":"ACS Cent Sci"},{"key":"10.1124\/jpet.122.001192_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13181-016-0588-y","article-title":"Suspected adulteration of commercial kratom products with 7-hydroxymitragynine","volume":"12","author":"Lydecker","year":"2016","journal-title":"J Med Toxicol"},{"key":"10.1124\/jpet.122.001192_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(96)00714-5","article-title":"Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems","volume":"317","author":"Matsumoto","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.122.001192_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1124\/jpet.122.001192_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00000542-199409000-00022","article-title":"Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats","volume":"81","author":"Meert","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.122.001192_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jnr.24695","article-title":"Pain management with opioids in adults","volume":"100","author":"Montgomery","year":"2022","journal-title":"J Neurosci Res"},{"key":"10.1124\/jpet.122.001192_bib27","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0022-3565(25)38595-2","article-title":"Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes","volume":"268","author":"O\u2019Rourke","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001192_bib28","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/acs.jmedchem.1c00028","article-title":"Novel approaches, drug candidates, and targets in pain drug discovery","volume":"64","author":"Obeng","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001192_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acs.jmedchem.9b01465","article-title":"Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based kratom alkaloids","volume":"63","author":"Obeng","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001192_bib30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.120.000189","article-title":"Pharmacological comparison of mitragynine and 7-hydroxymitragynine: in vitro affinity and efficacy for mu-opioid receptor and opioid-like behavioral effects in rats","volume":"376","author":"Obeng","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001192_bib31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-3565(25)23146-9","article-title":"An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates","volume":"255","author":"Ossipov","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001192_bib32","doi-asserted-by":"crossref","first-page":"PL71","DOI":"10.1016\/0024-3205(90)90530-5","article-title":"Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: isobolographic analysis","volume":"47","author":"Ossipov","year":"1990","journal-title":"Life Sci"},{"key":"10.1124\/jpet.122.001192_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0304-3959(92)90201-L","article-title":"Antinociceptive and motor effects of intrathecal morphine combined with intrathecal clonidine, noradrenaline, carbachol or midazolam in rats","volume":"49","author":"Plummer","year":"1992","journal-title":"Pain"},{"key":"10.1124\/jpet.122.001192_bib34","series-title":"R: A language and environment for statistical computing.","year":"2017"},{"key":"10.1124\/jpet.122.001192_bib35","first-page":"PL115","article-title":"Decreased spinal morphine\/clonidine antinociceptive synergism in morphine-tolerant mice","volume":"56","author":"Roerig","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/jpet.122.001192_bib36","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.3390\/ijms130911427","article-title":"Antinociceptive action of isolated mitragynine from Mitragyna Speciosa through activation of opioid receptor system","volume":"13","author":"Shamima","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.122.001192_bib37","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/dta.2604","article-title":"Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"11","author":"Sharma","year":"2019","journal-title":"Drug Test Anal"},{"key":"10.1124\/jpet.122.001192_bib38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2014.03.017","article-title":"Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users","volume":"139","author":"Singh","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.122.001192_bib39","series-title":"Statistical Methods","author":"Snedecor","year":"1967"},{"key":"10.1124\/jpet.122.001192_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-2999(79)90335-2","article-title":"Antinociceptive activity of clonidine and its potentiation of morphine analgesia","volume":"58","author":"Spaulding","year":"1979","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.122.001192_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109903","article-title":"Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects","volume":"9","author":"Stone","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001192_bib42","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1523\/JNEUROSCI.17-18-07157.1997","article-title":"The \u03b12a adrenergic receptor subtype mediates spinal analgesia evoked by \u03b12 agonists and is necessary for spinal adrenergic-opioid synergy","volume":"17","author":"Stone","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.122.001192_bib43","article-title":"Morphine and clonidine synergize to ameliorate low back pain in mice","volume":"2012","author":"Tajerian","year":"2012","journal-title":"Pain Res Treat"},{"key":"10.1124\/jpet.122.001192_bib44","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1016\/S0021-9258(17)39198-6","article-title":"Why does Coomassie Brilliant Blue R interact differently with different proteins? A partial answer","volume":"260","author":"Tal","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001192_bib45","series-title":"Drug Synergism and Dose-Effect Data Analysis","author":"Tallarida","year":"2000"},{"key":"10.1124\/jpet.122.001192_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3565(24)29450-7","article-title":"Drug synergism: its detection and applications","volume":"298","author":"Tallarida","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001192_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001192_bib48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bpa.2017.10.004","article-title":"Additives used to reduce perioperative opioid consumption 1: Alpha2-agonists","volume":"31","author":"Tonner","year":"2017","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1124\/jpet.122.001192_bib49","first-page":"319","article-title":"Body condition scoring: a rapid and accurate method for assessing health status in mice","volume":"49","author":"Ullman-Culler\u00e9","year":"1999","journal-title":"Lab Anim Sci"},{"key":"10.1124\/jpet.122.001192_bib50","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cvsm.2019.07.010","article-title":"Alternatives to opioid analgesia in small animal anesthesia: alpha-2 agonists","volume":"49","author":"Valverde","year":"2019","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1124\/jpet.122.001192_bib51","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with Mu agonism and delta antagonism, which do not recruit \u03b2-arrestin-2","volume":"59","author":"V\u00e1radi","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001192_bib52","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1213\/00000539-200209000-00033","article-title":"Combination spinal analgesic chemotherapy: a systematic review","volume":"95","author":"Walker","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.122.001192_bib53","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1124\/jpet.118.255844","article-title":"The effects of morphine, baclofen, and buspirone alone and in combination on schedule-controlled responding and hot plate antinociception in rats","volume":"370","author":"Wilkerson","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001192_bib54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2016.11.015","article-title":"The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice","volume":"114","author":"Wilkerson","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001192_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.115.229971","article-title":"The selective monoacylglycerol lipase inhibitor MJN110 produces opioid-sparing effects in a mouse neuropathic pain model","volume":"357","author":"Wilkerson","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001192_bib56","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s10571-020-01034-7","article-title":"Kratom alkaloids, natural and semi-synthetic, show less physical dependence and ameliorate opioid withdrawal","volume":"41","author":"Wilson","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"10.1124\/jpet.122.001192_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108310","article-title":"Lyophilized kratom tea as a therapeutic option for opioid dependence","volume":"216","author":"Wilson","year":"2020","journal-title":"Drug Alcohol Depend"}],"updated-by":[{"DOI":"10.1124\/jpet.122.001192err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524003513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524003513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:27:38Z","timestamp":1739953658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524003513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0022356524003513"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001192","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactive Effects of \u00b5-Opioid and Adrenergic-\u03b12 Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}